Long COVID Optimal Health Programme (LC-OHP) to enhance psychological and physical health: a feasibility randomised controlled trial protocol

Al-Jabr, Hiyam, Windle, Karen, Thompson, David, R., Jenkins, Zoe, Castle, David and Ski, Chantal (2022) Long COVID Optimal Health Programme (LC-OHP) to enhance psychological and physical health: a feasibility randomised controlled trial protocol. JMIR Research Protocols, 11 (5). pp. 1-12. ISSN 1929-0748 (In Press)

[img] Text
Manuscript with track changes.docx - Accepted Version
Restricted to Repository staff only

Download (151kB) | Request a copy
Long COVID.pdf - Published Version
Available under License Creative Commons Attribution.

Download (263kB) | Preview


Long COVID is a collection of symptoms that develop during or following a confirmed or suspected case of COVID-19, that continue for more than 12 weeks. Despite the negative impact of long COVID on people’s lives and functioning, there is no validated treatment or even rehabilitation guidance. What has been recommended thus far, is adoption of holistic management approaches. The Optimal Health Programme (OHP) is a brief 5-session, plus booster, psychosocial programme designed to support mental and physical wellbeing that has been used effectively for a range of chronic conditions.

This study examines the feasibility and acceptability of employing a specially customised version of OHP (long COVID OHP or LC-OHP) to improve psychological and physical health of people with long COVID.

This is a feasibility randomised controlled trial that will be running from November 2021 to October 2022. Eligible participants aged 18 years or older who are experiencing symptoms of long COVID will be identified through their secondary practitioners with recruitment to be undertaken by the research team. Sixty participants will be randomised into a control (usual care) or an intervention (LC-OHP) group. Outcomes will be feasibility and acceptability of the programme (primary); and efficacy of the LC-OHP in improving anxiety, depression, fatigue, self-efficacy and quality of life (secondary). Up to 20 participants will be interviewed at the end of the trial to explore their experience with the programme. Quantitative data will be analysed using SPSS and differences between groups will be compared using inferential tests where appropriate. Qualitative data will be transcribed and thematically analysed to identify common emerging themes.

This is an ongoing study which began in November 2021. The study received approval from the University of Suffolk Ethics committee (RETH21/004) and from the NHS Health Research Authority (IRAS no. 304234).

Long COVID has a significant impact on an individual’s mental and physical functioning. The LC-OHP has a potential to provide people living with long COVID with additional support and to improve self-efficacy. Findings of this study would identify the feasibility of delivering this programme to this population and will provide an indication for the programme’s effectiveness.

Item Type: Article
Uncontrolled Keywords: Long COVID, COVID-19, optimal health programme, telemedicine, integrated care
Subjects: R Medicine > R Medicine (General)
R Medicine > RZ Other systems of medicine
Divisions: Faculty of Health & Science > Department of Health Studies
Depositing User: Hiyam Al-jabr
Date Deposited: 16 Mar 2022 14:14
Last Modified: 01 Jun 2022 11:17
URI: https://oars.uos.ac.uk/id/eprint/2402

Actions (login required)

View Item View Item